Legro, R. S., Finegood, D., & Dunaif, A. (1998). A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism, 83(8), 2694-2698. https://doi.org/10.1210/jcem.83.8.5054
Legro RS, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1998;83(8):2694-2698. doi:10.1210/jcem.83.8.5054
Legro, Richard S., et al. "A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome." The Journal of Clinical Endocrinology and Metabolism, vol. 83, no. 8, 1998, pp. 2694-2698.
For EndNote, Zotero or Mendeley:
License
Open-access status not yet checked.
Author affiliations
2 institutions
Penn State Milton S. Hershey Medical Center01h22ap11
Fasting glucose-insulin ratio may flag insulin resistance in obese PCOS
In a screening study of 40 obese women with polyendocrine metabolic ovarian syndrome (PMOS), formerly polycystic ovary syndrome (PCOS), the fasting glucose-to-insulin ratio flagged about 95 out of 100 women with insulin resistance at the authors' cutoff. At that cutoff, about 84 out of 100 women without it had a normal ratio. The study also enrolled 15 matched controls.
Study at a glance, screening study of 40 obese women: Fasting glucose-to-insulin ratio flagged insulin resistance in obese women. Source: Legro RS et al., 1998, PMID 9709933.
Key Findings
In 40 women with the syndrome, insulin sensitivity correlated with the fasting glucose-to-insulin ratio at r = 0.73 (P < 0.0001) and with fasting insulin at r = 0.50 (P < 0.001).
Fasting glucose showed no significant correlation (r = 0.24; P = NS). The 2-hour ratio after an oral glucose drink was the only stronger correlation (r = 0.74; P < 0.001).
At the authors' cutoff, sensitivity (insulin-resistant women flagged) was 95% (20 of 21; 95% CI 86 to 100). Specificity (others cleared) was 84% (16 of 19; 95% CI 68 to 100).
Positive predictive value was 87% (20 of 23; 95% CI 73 to 100) and negative predictive value was 94% (16 of 17; 95% CI 83 to 100).
Using the 10th percentile of the controls' insulin sensitivity as the cutoff, 53% of the 40 women with the syndrome were insulin resistant. A 25th-percentile cutoff would have designated 80% as resistant.
Interpretation
The study tested a simple ratio against the frequently sampled intravenous glucose tolerance test, the standard lab test for insulin sensitivity. The study included 40 obese women with the syndrome and 15 matched women without it. The ratio tracked insulin sensitivity closely and flagged insulin resistance accurately in this group. The authors call for further studies in other groups of women to build on these findings.
RRM Context
Restorative reproductive medicine looks for the root causes of a condition. The authors state that high insulin levels play a role in the reproductive problems of the syndrome. A 2026 consensus in The Lancet gave the syndrome a new name, reflecting effects on several body systems.
Our editorial summary of this paper, not the article's abstract.
Abstract
Women with polycystic ovary syndrome (PCOS) are profoundly insulin resistant, and the resultant hyperinsulinemia exacerbates the reproductive abnormalities of the syndrome. Agents that ameliorate insulin resistance and reduce circulating insulin levels could provide a new therapeutic modality for PCOS. Identifying the subset of PCOS women who are most insulin resistant may therefore be useful for selecting women who will respond to this therapy. We examined the correlation of basal and oral glucose-stimulated glucose and insulin levels and fasting and stimulated glucose/insulin (G:I) ratios with parameters of insulin sensitivity obtained by frequently sampled i.v. glucose tolerance test (FSIGT) to assess whether there is a simple screening test for insulin resistance in PCOS. Forty PCOS women (aged 18-40 yr; body mass index, >26 kg/m2) and 15 control women matched for age, weight, and ethnicity underwent both a 75-g oral glucose tolerance test (OGTT) and a FSIGT. The insulin sensitivity index (S(I)) was calculated by application of the minimal model of glucose kinetics to the dynamics of plasma glucose and insulin levels during the FSIGT. The best correlation in PCOS between S(I) and a fasting level was found with fasting G:I ratios (r = 0.73; P < 0.0001). A less substantial, but significant, correlation was found with fasting insulin levels (r = 0.50; P < 0.001), and no significant correlation was found with fasting glucose levels (r = 0.24; P = NS). The fasting G:I was more strongly correlated with S(I) than with integrated glucose and insulin responses during the OGTT. The only stronger correlation was with the OGTT 2 h G:I ratio (r = 0.74; P < 0.001). Stepwise regression analysis with S(I) as the dependent variable and fasting glucose and insulin levels, area under the curve for glucose and insulin, and a fasting G:I ratio showed that only the fasting G:I ratio was significantly predictive of S(I) in the model (F to remove value = 38.1; P < 0.001). When viewed as a screening test for insulin resistance in PCOS, setting a value of the fasting G:I ratio of less than 4.5 as abnormal (using an S(I) value below the 10th percentile of our control population as evidence for insulin resistance), the sensitivity of a fasting G:I ratio was 95%, the specificity was 84%, the positive predictive value was 87%, and the negative predictive value was 94%. Receiver operator curve analysis showed that this fasting G:I ratio was the single best screening measure for detecting insulin resistance. We conclude that a fasting G:I ratio may be useful as a screening test for insulin resistance in obese non-Hispanic white PCOS women. This may be a clinically useful parameter for selecting PCOS women most likely to respond to therapeutic interventions that improve insulin sensitivity.